IBDEI2IH ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,42573,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42573,1,3,0)
 ;;=3^Dementia w/ Behavioral Disturbances,Unspec
 ;;^UTILITY(U,$J,358.3,42573,1,4,0)
 ;;=4^F03.91
 ;;^UTILITY(U,$J,358.3,42573,2)
 ;;=^5133350
 ;;^UTILITY(U,$J,358.3,42574,0)
 ;;=G31.83^^159^2024^14
 ;;^UTILITY(U,$J,358.3,42574,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42574,1,3,0)
 ;;=3^Dementia w/ Lewy Bodies
 ;;^UTILITY(U,$J,358.3,42574,1,4,0)
 ;;=4^G31.83
 ;;^UTILITY(U,$J,358.3,42574,2)
 ;;=^329888
 ;;^UTILITY(U,$J,358.3,42575,0)
 ;;=F01.51^^159^2024^30
 ;;^UTILITY(U,$J,358.3,42575,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42575,1,3,0)
 ;;=3^Vascular Dementia w/ Behavioral Disturbances
 ;;^UTILITY(U,$J,358.3,42575,1,4,0)
 ;;=4^F01.51
 ;;^UTILITY(U,$J,358.3,42575,2)
 ;;=^5003047
 ;;^UTILITY(U,$J,358.3,42576,0)
 ;;=F01.50^^159^2024^31
 ;;^UTILITY(U,$J,358.3,42576,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42576,1,3,0)
 ;;=3^Vascular Dementia w/o Behavioral Disturbances
 ;;^UTILITY(U,$J,358.3,42576,1,4,0)
 ;;=4^F01.50
 ;;^UTILITY(U,$J,358.3,42576,2)
 ;;=^5003046
 ;;^UTILITY(U,$J,358.3,42577,0)
 ;;=A81.9^^159^2024^6
 ;;^UTILITY(U,$J,358.3,42577,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42577,1,3,0)
 ;;=3^Atypical Virus Infection of CNS,Unspec
 ;;^UTILITY(U,$J,358.3,42577,1,4,0)
 ;;=4^A81.9
 ;;^UTILITY(U,$J,358.3,42577,2)
 ;;=^5000414
 ;;^UTILITY(U,$J,358.3,42578,0)
 ;;=A81.09^^159^2024^8
 ;;^UTILITY(U,$J,358.3,42578,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42578,1,3,0)
 ;;=3^Creutzfeldt-Jakob Disease NEC
 ;;^UTILITY(U,$J,358.3,42578,1,4,0)
 ;;=4^A81.09
 ;;^UTILITY(U,$J,358.3,42578,2)
 ;;=^5000410
 ;;^UTILITY(U,$J,358.3,42579,0)
 ;;=A81.00^^159^2024^9
 ;;^UTILITY(U,$J,358.3,42579,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42579,1,3,0)
 ;;=3^Creutzfeldt-Jakob Disease,Unspec
 ;;^UTILITY(U,$J,358.3,42579,1,4,0)
 ;;=4^A81.00
 ;;^UTILITY(U,$J,358.3,42579,2)
 ;;=^5000409
 ;;^UTILITY(U,$J,358.3,42580,0)
 ;;=A81.01^^159^2024^10
 ;;^UTILITY(U,$J,358.3,42580,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42580,1,3,0)
 ;;=3^Creutzfeldt-Jakob Disease,Variant
 ;;^UTILITY(U,$J,358.3,42580,1,4,0)
 ;;=4^A81.01
 ;;^UTILITY(U,$J,358.3,42580,2)
 ;;=^336701
 ;;^UTILITY(U,$J,358.3,42581,0)
 ;;=A81.89^^159^2024^7
 ;;^UTILITY(U,$J,358.3,42581,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42581,1,3,0)
 ;;=3^Atypical Virus Infections of CNS NEC
 ;;^UTILITY(U,$J,358.3,42581,1,4,0)
 ;;=4^A81.89
 ;;^UTILITY(U,$J,358.3,42581,2)
 ;;=^5000413
 ;;^UTILITY(U,$J,358.3,42582,0)
 ;;=A81.2^^159^2024^27
 ;;^UTILITY(U,$J,358.3,42582,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42582,1,3,0)
 ;;=3^Progressive Multifocal Leukoencephalopathy
 ;;^UTILITY(U,$J,358.3,42582,1,4,0)
 ;;=4^A81.2
 ;;^UTILITY(U,$J,358.3,42582,2)
 ;;=^5000411
 ;;^UTILITY(U,$J,358.3,42583,0)
 ;;=B20.^^159^2024^17
 ;;^UTILITY(U,$J,358.3,42583,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42583,1,3,0)
 ;;=3^HIV Disease w/ Dementia w/ Behavioral Disturbances
 ;;^UTILITY(U,$J,358.3,42583,1,4,0)
 ;;=4^B20.
 ;;^UTILITY(U,$J,358.3,42583,2)
 ;;=^5000555^F02.81
 ;;^UTILITY(U,$J,358.3,42584,0)
 ;;=B20.^^159^2024^18
 ;;^UTILITY(U,$J,358.3,42584,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42584,1,3,0)
 ;;=3^HIV Disease w/ Dementia w/o Behavioral Disturbances
 ;;^UTILITY(U,$J,358.3,42584,1,4,0)
 ;;=4^B20.
 ;;^UTILITY(U,$J,358.3,42584,2)
 ;;=^5000555^F02.80
 ;;^UTILITY(U,$J,358.3,42585,0)
 ;;=F10.27^^159^2024^1
 ;;^UTILITY(U,$J,358.3,42585,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42585,1,3,0)
 ;;=3^Alcohol Dependence w/ Alcohol-Induced Persisting Dementia
 ;;^UTILITY(U,$J,358.3,42585,1,4,0)
 ;;=4^F10.27
